Podcasts about Early Stage

  • 1,102PODCASTS
  • 1,858EPISODES
  • 35mAVG DURATION
  • 1DAILY NEW EPISODE
  • Nov 11, 2022LATEST

POPULARITY

20152016201720182019202020212022

Categories



Best podcasts about Early Stage

Show all podcasts related to early stage

Latest podcast episodes about Early Stage

Equity
It's not a rug pull if it's an accident

Equity

Play Episode Listen Later Nov 11, 2022 37:55


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.We thought that last week was a lot. It was, but this week was somehow more. More chaotic, rapid-fire change at a number of massive tech companies kept us on our toes. So, while our beloved co-host Natasha was out, we couldn't do the recording down a set of hands, so we brought Becca aboard with Mary Ann and Alex.The list of news was so long that we were cutting entire sections up until we hit record, and even still we went over time. If you like longer episodes, this one is for you.Deals of the Week: What's going on with the former Peloton CEO's new rug startup? And how is Tellus going to offer much better consumer savings rates? And, finally, how wrong can Alex get the Harmonic business model until he figures it out live on the show?Mega-layoffs: From there, we had to sit down and discuss the massive Meta layoffs. Our read is that the company is doing right by the folks it is cutting, which is not as much as we can say about some other companies in the world also undergoing massive staffing cuts. Naturally, this brought up Twitter to a degree, the smaller social network being the Main Character in tech news up until, well:WTF FTX? Ah, FTX. Last week it was worth $32 billion and its founder was arguably the face of crypto around the world. And now Sequoia has pulled its on-site hagiography, SBF is a pariah, and FTX may be going to zero. There's going to be a mini-series about this, isn't there?We are back Monday! Have a lovely weekend!Equity drops at 7 a.m. PT every Monday and Wednesday, and at 6 a.m. PT on Fridays, so subscribe to us on Apple Podcasts, Overcast, Spotifyand all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, one that details how our stories come together, and more!

This Much I Know - The Seedcamp Podcast
How to set up customer support and operations as an early-stage startup

This Much I Know - The Seedcamp Podcast

Play Episode Listen Later Nov 9, 2022 21:41


In our latest edition of Seedcamp Firsts, our Head of Brand and Network, Natasha Lytton, speaks with one of our fantastic mentors, Rona Ruthen, about setting up customer support and operations in early-stage startups. Rona is one of the best possible people to learn from on this topic following her experience scaling Fintech unicorn Monzo among other well-known startups, including Seedcamp portfolio company Curve. Learn why setting up customer operations is a strategic decision, why customer experience is critical for every product that we use and care about, and why you want customers to engage with the product and make that whole experience easy, end to end. Furthermore, find out why, as you start scaling customer support, you need more consistency and standardisation in how you respond to customers and how you interact with them. Read our Deep Dive Q&A with Rona: sdca.mp/Customers_Operations Stay tuned for Part II, where Rona will join us to go much deeper into everything around scaling, where change is the only constant. We'll be delving much more into how you can bring teams on the journey with you and whole companies and embrace change, which becomes different challenges, but no less change as you go on that scaling journey. Show notes: Rona Ruthen - twitter.com/RonaRuthen Natasha Lytton - twitter.com/Natashalytton Seedcamp - seedcamp.com

Equity
Tech layoffs may get worse before they get better

Equity

Play Episode Listen Later Nov 9, 2022 34:05


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.This is our Wednesday show, where we niche down to a single person, think about their work, and unpack the rest. This week, Natasha interviewed Nolan Church, the CEO and co-founder of Continuum, about his perspective on the tech layoff wave. While we do indeed get into how his vision of fractional work fits into this conversation, we start with the fact that Church helped conduct Carta's layoffs in 2020 (a low of his entire career, he says) and what that experience taught him about the importance of being direct. Here are a few of the topics we get into:Twitter's recent layoffs, Jack's silence and who should take ownership for whatThe generic CEO statement on macroeconomic challengesStripe's recent layoffsWhat is the best way to conduct a layoff, and how should you communicate with staff? How does that change based on stage?Is the rumor that all startups should just cut 20% of staff to extend runway accurate at all?If Church could go back in time, would he change anything about the way that Carta conducted its layoffs?What executive role is most likely to be disrupted and why Q1 may bring more doom and gloom into the tech sphereAnd finally, Church's attempt to summarize all of 2022 in a headline (I don't disagree with his final answer, by the way).From Natasha: I'll fully take ownership for the fact that my column from just two weeks ago (!) has poorly aged. If you or someone you know is whipping up a cool program - like this -  to support those laid off, hit me up on Twitter and I may just create a good news show.Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

Equity
One day all tech news will merely be updates to Twitter moderation policies

Equity

Play Episode Listen Later Nov 7, 2022 8:00


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.Stocks are up around the world, which is a nice thing to wake up to. Crypto prices are down a smidgen, but nothing majorThere's FTX-Binance drama afoot, in case that's your jam.On the Twitter beat, in the wake of rehires Musk is tweaking his work on moderation policies regarding impersonation, verification appears to be on hold, and more.PhotoRoom raised $19 million, the Unity megadeal is complete, no matter what we thought about it, and Yassir just raised $150 million from Bond. Has Bond been quiet lately? Not sure but dang, this round was a big one.There's an election tomorrow in America.And that's our show! More Wednesday!Equity drops at 7 a.m. PT every Monday and Wednesday, and at 6 a.m. PT on Fridays, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, one that details how our stories come together, and more!

Smart Business Dealmakers
Kit Needham, Director of Project Olympus, Carnegie Mellon University

Smart Business Dealmakers

Play Episode Listen Later Nov 4, 2022 26:47


Kit Needham directs Project Olympus, Carnegie Mellon University's incubator that helps students, faculty and alums turn their ideas into viable businesses. She discusses the very earliest stages of entrepreneurism, what tends to trip folks up at this stage and how her experience as an investor informs her approach to coaching the next generation of entrepreneurs.

Smart Business Dealmakers
Eric Sheinkop, CEO of The Desire Company

Smart Business Dealmakers

Play Episode Listen Later Nov 4, 2022 23:31


The Desire Company matches and retailers with the right experts to trial, test and review products, producing video reviews for use at the point of sale and across digital marketing channels. These partnerships are proving to drive an increase in conversions, time on site and an increase in marketing effectiveness. Co-founder and CEO Eric Sheinkop discusses the creation of The Desire Company, his experience raising capital for the startup and place for the future.

PodKast de K Fund
#171: Sançar Sahin(Oliva): proper mental health, brand building and content at early stage startups

PodKast de K Fund

Play Episode Listen Later Nov 4, 2022 75:50


In today's episode we interview Sançar Sahin, co-founder of Oliva, a startup that provides "proper mental health support for employees". Prior to building Oliva, Sançar held several senior marketing roles at startups such as Typeform, Hotjar and Getapp. He also was the first marketing hire at Typeform, at a time when the company had only 30 employees and $500K in ARR, helping it build all the way to $30M in ARR by the time that he left. In this episode we chat with Sançar about: - His marketing experience as an operator - The relevance and importance of brand building and content at an early stage startup - How to combine content marketing with performance marketing - His struggles as an operator and how that had an impact in his mental health - The journey to founding Oliva - What they mean when they say that they provide "proper" mental health - And many other topics Sançar's book recommendation is "The Subtle Art Of Not Giving A Fxck: A Counterintuitive Approach to Living a Good Life" https://www.linkedin.com/in/sancarsahin/ https://www.oliva.health/

Mission: DeFi
DeFi Lunch (Ep 229) - Nov 2, 2022 - @DefiIgnas early stage projects

Mission: DeFi

Play Episode Listen Later Nov 3, 2022 56:52


Haym Salomon - https://mobile.twitter.com/SalomonCrypto Introducing: Salomon Rollup - by Haym Salomon - https://salomoncrypto.substack.com/p/introducing-salomon-rollup?utm_source=twitter&utm_campaign=auto_share&r=1f5x9c Nikolai Muchgian has died - https://twitter.com/OmniCraig/status/1586432239105060864 .P. Morgan has executed its 1st LIVE trade on public blockchain using DeFi - https://twitter.com/TyLobban/status/1587679344792829954

Million Dollar Mastermind with Larry Weidel
Episode #546 - The Early Stages Of Business Building with Heather Smith

Million Dollar Mastermind with Larry Weidel

Play Episode Listen Later Nov 2, 2022 13:55


In this episode of the Million Dollar Mastermind podcast, host Larry Weidel is joined by Heather Smith, Co-Founder, President, and Chief Visionary Officer at StoryFile.

Equity
Twitter is a startup again, I guess

Equity

Play Episode Listen Later Oct 31, 2022 9:41


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.Stocks are mixed around the world, notably lower in China on the back of some negative economic data, and down in the United States ahead of what is expected to be another rise in interest rates thanks to the Federal Reserve. Crypto prices have held onto recent gains.A busy weekend of Twitter leaks lead the news cycle. Precisely if, and if yes, how much, Twitter can charge for verified accounts to keep their badge is now a point of conversation. Other reports of development deadlines with termination held as a threat if they are not met are likely doing great things for staffer morale.It turns out that self-driving cars are still far away. I am crying.Startups Zebra Labs and Invygo raised money, showing that the global startup investment market has not frozen, and that there is still funding for more future-facing efforts like Zebra in the metaverse.Finally, we're keeping close tabs on the Q4 venture capital cycle. If we don't see a rebound soon, how many unicorns die?And that's our show! More Wednesday!Equity drops at 7 a.m. PT every Monday and Wednesday, and at 6 a.m. PT on Fridays, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, one that details how our stories come together, and more!

Revenue Generator Podcast: Sales + Marketing + Product + Customer Success = Revenue Growth
Leading Product Development At Early Stage Startups vs Tech Giants -- Karthik Suresh // Ignition

Revenue Generator Podcast: Sales + Marketing + Product + Customer Success = Revenue Growth

Play Episode Listen Later Oct 31, 2022 18:15


Karthik Suresh, Co-Founder of Ignition, talks about product management in big tech vs startups. Product management at early stage startups differs incredibly from product management at an established company. However, while the day-to-day duties are different, product leaders within mature organizations will still find themselves leaning on similar skill sets they would have leaned on at the start up level. Today, Karthik discusses leading product development at early stage startups vs tech giants. Show Notes Connect With: Karthik Suresh: Website // LinkedIn // TwitterThe Rev Gen Podcast: Email // LinkedIn // TwitterI Hear Everything: IHearEverything.com // LinkedIn // Twitter See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Equity
I regret to inform you that Elon has something to do with this

Equity

Play Episode Listen Later Oct 28, 2022 34:57 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.We hope that you are in good form this Friday, alive, well, and ready to rock. We certainly were. And in a change of pace, as our dear Mary Ann was off this week, the excellent Anita Ramaswamy joined Natasha Mascarenhas and Alex Wilhelm on the mics. (Theresa, as per usual, held down the production front!)What did we merry three get into? The following:Quick Hits: Launch House is shaking up its legal team as it sifts through what is left of its reputation; Sequoia India is still making big edtech bets; and BeReal is wealthy and, in our view, pretty cool. But does it have the staying power it will need?Twitter layoffs: When we prepped for the show, it seemed that massive Twitter layoffs could impact up to 75% of the company's staff. Since then, the figure has come down some. How much? That's not clear, but what is is the fact that Twitter's new chapter is supposed to begin, and soon.King Apple: The multi-front war attacking Apple's massive, and pervasive demand that it gets 30% of all transaction value on the App Store continues to rack up detractors. This time? NFT and other crypto fans. China: We closed on a brief riff on Chinese startups!We are back Monday for a spooky episode!Equity drops at 7 a.m. PT every Monday and Wednesday, and at 6 a.m. PT on Fridays, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, one that details how our stories come together, and more!

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast
Brendon M. Stiles, MD - Precision Decisions in Multimodal Management of Early-Stage NSCLC: Integrating EGFR-Targeted Therapy in Perioperative Settings

PeerView Heart, Lung & Blood CME/CNE/CPE Video Podcast

Play Episode Listen Later Oct 28, 2022 41:23


Go online to PeerView.com/WRG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Approximately 40% of patients with early-stage lung cancer experience disease recurrence within 1 year of receiving curative-intent surgery, representing a significant unmet medical need. Management of patients with NSCLC should be individualized based on a number of factors, including the molecular profile of the patient's tumor and the benefits and limitations of therapeutic options in the context of the latest evidence. Continued advances with targeted therapies have prompted strong interest in expanding their use into earlier disease settings, and adjuvant EGFR-targeted therapy has demonstrated remarkable efficacy in early-stage NSCLC, leading to the first regulatory approval of osimertinib as adjuvant therapy after resection in patients with NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations. Early findings from studies in the neoadjuvant setting are beginning to emerge now as well, as perioperative use of EGFR-targeted therapy continues to demonstrate improved outcomes. As part of the multidisciplinary team, thoracic surgeons play an essential role in collaborating and coordinating with other specialists to determine the best treatment plan, including incorporating EGFR-targeted therapy into multimodal management strategies. This PeerView educational video, based on a recent live symposium, provides an essential overview of the latest clinical evidence supporting the use of EGFR-targeted therapy in perioperative settings, as well as practical advice for optimal integration of targeted therapies in practice or as part of a clinical trial. Multidisciplinary discussions on the new practice-changing data highlight important implications for the surgeon–oncologist partnership, utilizing EGFR-targeted therapy as part of multimodal management of patients with resectable NSCLC with the goal of improving outcomes and quality of life. Upon completion of this activity, participants should be better able to: Review the role of EGFR mutations in NSCLC, advances in EGFR-targeted therapy in earlier disease settings, and importance of identifying patients who might benefit from these therapies in perioperative settings; Apply the latest evidence and guidelines to identify patients with early-stage resectable NSCLC who are candidates for adjuvant EGFR-targeted therapy or investigational targeted approaches; Collaborate with the multidisciplinary team to integrate EGFR-targeted therapy into multimodal treatment plans for eligible patients with early-stage resectable NSCLC

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast
Brendon M. Stiles, MD - Precision Decisions in Multimodal Management of Early-Stage NSCLC: Integrating EGFR-Targeted Therapy in Perioperative Settings

PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

Play Episode Listen Later Oct 28, 2022 41:17


Go online to PeerView.com/WRG860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Approximately 40% of patients with early-stage lung cancer experience disease recurrence within 1 year of receiving curative-intent surgery, representing a significant unmet medical need. Management of patients with NSCLC should be individualized based on a number of factors, including the molecular profile of the patient's tumor and the benefits and limitations of therapeutic options in the context of the latest evidence. Continued advances with targeted therapies have prompted strong interest in expanding their use into earlier disease settings, and adjuvant EGFR-targeted therapy has demonstrated remarkable efficacy in early-stage NSCLC, leading to the first regulatory approval of osimertinib as adjuvant therapy after resection in patients with NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations. Early findings from studies in the neoadjuvant setting are beginning to emerge now as well, as perioperative use of EGFR-targeted therapy continues to demonstrate improved outcomes. As part of the multidisciplinary team, thoracic surgeons play an essential role in collaborating and coordinating with other specialists to determine the best treatment plan, including incorporating EGFR-targeted therapy into multimodal management strategies. This PeerView educational video, based on a recent live symposium, provides an essential overview of the latest clinical evidence supporting the use of EGFR-targeted therapy in perioperative settings, as well as practical advice for optimal integration of targeted therapies in practice or as part of a clinical trial. Multidisciplinary discussions on the new practice-changing data highlight important implications for the surgeon–oncologist partnership, utilizing EGFR-targeted therapy as part of multimodal management of patients with resectable NSCLC with the goal of improving outcomes and quality of life. Upon completion of this activity, participants should be better able to: Review the role of EGFR mutations in NSCLC, advances in EGFR-targeted therapy in earlier disease settings, and importance of identifying patients who might benefit from these therapies in perioperative settings; Apply the latest evidence and guidelines to identify patients with early-stage resectable NSCLC who are candidates for adjuvant EGFR-targeted therapy or investigational targeted approaches; Collaborate with the multidisciplinary team to integrate EGFR-targeted therapy into multimodal treatment plans for eligible patients with early-stage resectable NSCLC

Equity
Yes, Chief

Equity

Play Episode Listen Later Oct 26, 2022 28:40 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.This is our Wednesday show, where we niche down to a single topic, think about a question and unpack the rest. This week, Natasha is bringing one of her favorite Disrupt panels to your ears. She sat down with Chief co-founders Lindsay Kaplan and Carolyn Childers to talk about the future of their private membership club for women in leadership positions. (Shout out Bryce for this amazing live illustration he did while we were all on stage!).The conversation touches on outlasting competitors, pandemic-defined community, the duality unicorn valuations and the word girlboss. If you love the conversation, share it with a friend. And if you want more on Chief, read a recap post that my colleague Ron Miller wrote about all things membership community and waitlists. Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

Gynecologic Oncology
October 2022 Editor's Choice: How do you manage the contralateral groin in early stage vulvar cancer with a unilateral positive sentinel lymph node?

Gynecologic Oncology

Play Episode Listen Later Oct 25, 2022 22:24


Hosted by: S. Diane Yamada, MD, Deputy Editor of Gynecologic Oncology Featuring: Maaike Oonk, MD, University Medical Center Groningen, University of Groningen, The Netherlands Akila Viswanathan, MD, MPH, Johns Hopkins Medicine Editor's Choice Paper: Unilateral inguinofemoral lymphadenectomy in patients with early-stage vulvar squamous cell carcinoma and a unilateral metastatic sentinel lymph node is safe Editorial:When is it safe to omit contralateral groin management in unilateral sentinel node-positive early stage vulvar cancer?

Equity
Seeing startups tackle the health of our planet is giving me life

Equity

Play Episode Listen Later Oct 24, 2022 10:07 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.We are back from Disrupt, which means we're picking up the pieces of our work lives, getting back on track. Equity is now on its regular schedule, which is good. A big thanks to the entire podcast production crew for making last week happen.Now! What did we get into this morning? The following:Stocks rallied around the world, but fell in China. Chinese equities suffered under investor pessimism at the cementing of Xi Jinping's authority over the country's economy. Elsewhere, hope that central bank policies would not carry as much teeth in the future as we have seen in recent months sent stocks higher.The finalists from the recent Startup Battlefield competition were all pretty freaking great, especially the focus that several had on making our home planet a bit cleaner, or better. Commercial solutions will be required for us to do any damn thing about the planet, so, here's to the companies working on it.Minerva Lithium wound up winning, which seemed legit given the sheer need we have as a people for lithium these days (it figures in battery production).Other points of conversation: No Instacart IPO coming, Yat Siu is still bullish on crypto games, and it is earnings season!Ok, chat soon!Equity drops at 7 a.m. PT every Monday and Wednesday, and at 6 a.m. PT on Fridays, so subscribe to us on Apple Podcasts, Overcast, Spotifyand all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, one that details how our stories come together, and more!

The Jason Cavness Experience
Josh Carter - US Navy Vet, a serial entrepreneur, a speaker, a podcast host, and a mentor for early stage startups.

The Jason Cavness Experience

Play Episode Listen Later Oct 23, 2022 124:18


On this replay of The Jason Cavness Experience I talk to Josh Carter. Josh is a US Navy Vet, a serial entrepreneur, a speaker, a podcast host, and a mentor for early stage startups. Our Affiliates Close.com - If you hate your sales CRM or know that you inevitably need to make a change because what you have is not working, certainly check out Close. It's quick and easy to set up and sales rep adoption is extremely high! Give their trial a shot. PeopleKeep - If your company has 49 or fewer employees a PeopleKeep personalized benefits advisor can evaluate whether a health reimbursement arrangement (HRA) is right for your business. Reach out today to get your questions answered. https://www.peoplekeep.com/cavnesshr Everee Payroll - Run payroll or contractor payments from anywhere in seconds with just one swipe on a mobile app. Focus on growing your business instead of on compliance. We remit, file and report on federal, state, local and unemployment insurance taxes, as well as handle your W2s and 1099s. https://offers.everee.com/cavness-hr CavnessHR - CavnessHR delivers HR companies with 49 or fewer people with our HR platform and by providing you access to your own HRBP. www.CavnessHR.com We talk about the following His Podcasts Operation Code 1859 Ventures When should founders switch from MVP/Product Market fit to all out scaling. Blue Ventures/Maritime Blue Innovation Accelerator at Washington Maritime Blue Josh's Bio Josh Carter is a US Navy Vet, a serial entrepreneur, a speaker, a podcast host, and a mentor for early stage startups. Born in the San Francisco Bay Area he spent time traveling the globe before settling into a career in telecom. For over 15 years he worked for companies like Pacific Bell, Google, and Twilio on a variety of large scale projects. Having started a number of companies he has led teams working on projects for companies like Disney, Pabst Blue Ribbon, Taco Bell, and many more. He led BrightWork, a developer infrastructure company, into top tier accelerator program Techstars and helped secure some venture funding. Josh also led a Techstars affiliated non-profit called Patriot Boot Camp where he was instrumental in creating new programs and partnerships. Today Josh hosts veteran and music focused podcasts and continues to work with early stage startups. He also hosts a monthly meetup for founders in the area called Coffee w/ Co-Founders. When he's not found at local meetups and events, you can find Josh with his family hiking or kayaking. Josh's Social Media 1859 VC: https://1859.vc/ Josh's LinkedIn: https://www.linkedin.com/in/joshuajcarter/ Josh's Email: josh@1859.vc Veteran Founder Podcast: https://podcasts.apple.com/us/podcast/veteran-founder-podcast/id1451751700 The Five10 Podcast: http://thefive10.com Josh's Gift I would love to sit down with any listener who is thinking about starting a business or has a business. I'm happy to spend some time and talk to your listeners about their idea. Anybody that wants to chat with me, my email is just josh@1859.vc They can email me and I'll give them my calendar link so that they can book some time at their convenience. We'll sit down and figure out what you're working on. I'm happy to help. Josh's Advice I tell this a lot to founders, your business is a hypothesis, until someone gives you money, it's not a business. If you treat your business like a science experiment. Write down your hypothesis, collect data, be obsessed with collecting data. Put numbers on paper, numbers won't lie. If you do all that, you're gonna set yourself up for success. If you ignore the data or not be authentic about it, or if you compromise that in any way, then you're going to be in a path for failure.

StrictlyVC Download
Early Stage Startups Still Attracting Big Checks, Says Matrix Partners' Antonio Rodriguez

StrictlyVC Download

Play Episode Listen Later Oct 22, 2022 33:29 Very Popular


Connie & Alex talk tech news, and then Connie chats with Antonio Rodriguez of Matrix Partners about the firm's focus on software infrastructure and why it pays to bet early. 

The SaaS Podcast - SaaS, Startups, Growth Hacking & Entrepreneurship
329: Hint: Building Customer Trust as an Early-Stage SaaS Startup - With Zak Holdsworth

The SaaS Podcast - SaaS, Startups, Growth Hacking & Entrepreneurship

Play Episode Listen Later Oct 20, 2022 59:38 Very Popular


Zak Holdsworth is the co-founder and CEO of Hint Health which is a membership management, billing, and payment software for primary care, urgent care, and speciality practices. Show Notes: • https://saasclub.io/329 Join Our Email List • Get weekly SaaS learnings, new podcast episodes, and actionable insights right in your inbox: https://saasclub.io/email/ Join Our Community for Free • SaaS Club is the community for early-stage SaaS founders and entrepreneurs: https://saasclub.co/join

Equity
Well, that was Fast: Equity Live at TechCrunch Disrupt

Equity

Play Episode Listen Later Oct 19, 2022 29:12 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. And for the first time in the history of the show, the TechCrunch pod that opened up Disrupt on the big stage. Alex, Natasha and Mary Ann got to be together to record in person for the first-time ever, and it went exactly as wild as you thought it would (we forgot this is what make up feels like!).We started with a deal of the week, which, in typical Equity style, had to be about a snarky comeback story and inequity. Then we spoke about our three themes of the year, ranging from reputation checks to scrappy requests to, of course, grace as a leadership style.Natasha wanted to talk about, in her own words, the nuance of reputation but more importantly when it matters versus when it's ignored.Alex wanted to riff on starting being forced to learn how to be scrappy, after a long period of being perhaps over-stuffed.And, finally, Mary Ann wanted to discuss the importance of humility. Which, frankly, is not something that we talk about enough.Thank you to everyone who came out to our live show, and for those who didn't, hope you enjoy and meet us next year. Onward!Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

This Much I Know - The Seedcamp Podcast
How to test, explore and validate your first product ideas as an early-stage startup

This Much I Know - The Seedcamp Podcast

Play Episode Listen Later Oct 19, 2022 42:14


We're excited to kick off our new Seedcamp Firsts series with Jo Widawski, co-founder and CEO of Maze. In conversation with our Venture partner, Devin Hunt, Jo shares the founding story of Maze and his top insights into early-stage product development. Our ultimate goal with Seedcamp Firsts is to help support the next generation of exceptional entrepreneurs navigate those critical first steps in building a business. We want to open up the hard-won knowledge and insights across the Seedcamp Nation – from the exceptional founders we've backed to our mentors, Experts in Residence, Venture partners, and our core team. Stay tuned!

Equity
Good morning! We regret to inform you that the wealthy are at it again

Equity

Play Episode Listen Later Oct 17, 2022 8:47 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.Don't forget that the code “EQUITY” can save you money on Disrupt tickets and TechCrunch+ access. And it makes us here on the show look good!Hell yeah, this is our Monday show. And heck yes, we are recording Equity live tomorrow morning at Disrupt. Get super stoked, because we are hype. That said, we did have a lot to get news done for you this morning. Here's what Theresa and Alex went through this morning:Stocks are up in many parts of the world, including the United States, where software shares are ripping north as the week begins. Very kind of the market to kick off Disrupt with some good news.Crypto is quieter, with prices not changing much and the general vibe of the market not evolving a whit.Kanye West, also known as Ye, is buying niche social network Parler in a deal that will see the musician, fashion mogul, and controversy generator buy the service — but not the infrastructure that powers it. Parler is not very popular at the moment and has stiff competition from other various celebrity-owned (or soon-to-be celebrity-owned) social networks Truth Social and Twitter.It is worth noting that West bought Parler after running into trouble with mainstream social services over his antisemitic posts.Ambi Robotics raised new capital, as did Byju's, and the Chinese chip industry is in turmoil after the United States kicked it in the shins.Woo! That's our show. We will see you tomorrow morning at Disrupt! Come and get an Equity pin and be The Coolest.Equity drops at 7 a.m. PT every Monday and Wednesday, and at 6 a.m. PT on Fridays, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, one that details how our stories come together, and more!

Equity
What's the TAM of the 1%?

Equity

Play Episode Listen Later Oct 14, 2022 35:26 Very Popular


AUDIOHello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. Before we get into this week's show notes, some programming items:First up, use code “EQUITY” for a special listener discount for Disrupt tickets. We're mere days away, and you should come hang out with us when we record on opening day!We also have a special for those impacted by layoffs. If you were laid off, go here to get a free ticket to TechCrunch Disrupt's Expo!That behind us, what did Mary Ann, Natasha and Alex get into today? A whole host of things. Here's the rundown: Getaway and Pacaso: What happens if you mix Airbnb, vacation homes, timeshares, and REITs? A very interesting startup cluster, it turns out. These two companies brought Mary Ann and Natasha into the same reporting space and gave us a good chance to discuss the luxury market.The Muse gets acquisitive: One of the most interesting deals we saw in the last week was The Muse buying Fairygodboss, a recruiting platform aimed at working mothers. The deal got us thinking about roll-ups in various sectors of the startup market, and where we might first see more activity. As Natasha recently put it in Startups Weekly, here's three words to consider about the market right now: Toil, Trouble, Startup Acquisitions. Party/Hangover: Mary Ann's weekly column, The Interchange, is a brill focused look at the latest (and sometimes the not-so-greatest) in fintech. We talk about her recent interview with Index's Mark Goldberg, and why he's talking about the party being over and crypto a side character.Q3 VC: Alex is digging through Q3 venture capital data as quickly as possible, working to get an understanding of where things are. It appears that United States-based venture activity is hanging in there, while the picture is a bit more dire globally. Elsewhere, fintech investment is falling, as is dealmaking in crypto-land.Ownership for all: We end with a look at some recent efforts to challenge venture's traditional structure. Shout out to Chattanooga's Brickyard, which recently raised a $17 million fund, on giving founders 10% of the GP's carried interest in the new fund. Sharing is caring. And really, it's just fair.OK! That's it! It's time to pack up and make the trip to San Francisco, where we cannot wait to see your pretty faces. Chat soon!Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

Equity
Sarah Guo isn't late to the AI party

Equity

Play Episode Listen Later Oct 12, 2022 38:23 Very Popular


Sarah Guo isn't late to the AI party, but she did just raise a $101 million fund to bet on the appetizers.Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. This is our Wednesday show, where we niche down to a single person, think about their work, and unpack the rest. This week, Natasha and Alex interviewed Guo, who worked at Greylock for nearly a decade, and her launch of Conviction. We spoke about the self-correcting venture market, what made her leave Greylock, and even rewound to her last episode with us (recorded almost exactly three years ago). There was also an especially fruitful conversation about the opportunity in artificial intelligence right now, and how she's defining Software 3.0. (Warning: We talk about SaaS!) We also dug into why she started a fund, the LP market, and more. The conversation ran a bit long, but it felt reasonable to keep going given the sheer breadth of stuff that we wanted to get through.Don't forget that Equity is going to be live at Disrupt next week, on Tuesday morning. It's going to be a blast. And before we go, two programming notes (that help your wallet, too):First up, use code “EQUITY” for a special listener discount for Disrupt tickets. We're less than one month away!We also have a special for those impacted by layoffs. If you were laid off, go here to get a free ticket to TechCrunch Disrupt's Expo.Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

Equity
It would be nice to not talk about Elon Musk for a bit

Equity

Play Episode Listen Later Oct 10, 2022 9:32 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.Don't forget that the code “EQUITY” can save you money on Disrupt tickets and TechCrunch+ access. And it makes us here on the show look good!We're gearing up to take the show on the road in short order, but don't worry about that this week. Service will continue as usual until we kick off Disrupt next Tuesday!Today, we got into the weeds about:Markets: Stocks are down in most of the world, albeit somewhat mixed in Europe. Crypto is mostly flat, with the XRP breaking the trend by being interesting. The Block reports that crypto volumes ticked higher in September, which could bode well.Startups: Clerkenwell Health just raised a couple million pounds for testing alternative medications for mental health conditions. We're excited about that. And Trendsi raised a $25 million Series A, which is no small deal, as we had expected to see smaller early-stage rounds this year. Good on Trendsi!Quick Hits: Kanye West and Elon Musk once again took over the news cycle, this time after the former got into trouble for anti-Semitic posts on Instagram and Twitter. In between, Musk welcomed Ye back to Twitter. Also Tizen is not dead, and PayPal is having a hellish start to the week.Don't forget: We are live next week on the first day of Disrupt! Come hang!More to come Wednesday, and Friday. I can't wait!Equity drops at 7 a.m. PT every Monday and Wednesday, and at 6 a.m. PT on Fridays, so subscribe to us on Apple Podcasts, Overcast, Spotifyand all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, one that details how our stories come together, and more!

Uncharted Podcast
#143: Leveraging Core Values as a Competitive Advantage And the Essential Nature of In-Person Work For Early-Stage Startups featuring Cristina Vila

Uncharted Podcast

Play Episode Listen Later Oct 10, 2022 15:17


This week's episode features Cristina Vila. Cristina is the CEO and Co-Founder of Cledara, a leading platform that combines management tools for teams with a payments platform to help companies take control of the software they use to run their business. Cristina won the 2021 EMEA Women in Payments Unicorn Challenge and was featured in Forbes Spain as one of the 21 changemakers of the year for the work Cledara is doing in reshaping how companies think about software. She was also chosen as one of the top 5 Female-Founders in Enterprise SaaS outside of the US by Melinda Gates' Pivotal Ventures and Microsoft's M12. You can follow Cristina on LinkedIn: https://www.linkedin.com/in/cvilavives This episode is brought to you with the support of Indeed, learn more at Indeed.com/scale --- Support this podcast: https://anchor.fm/uncharted1/support

Equity
Musk and Kardashian remind us to stop crying for the wealthy

Equity

Play Episode Listen Later Oct 7, 2022 30:58 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. Before we get into this week's show notes, some programming notes:First up, use code “EQUITY” for a special listener discount for Disrupt tickets. We're mere weeks away, and you should come hang out with us when we record on opening day!We also have a special for those impacted by layoffs. If you were laid off, go here to get a free ticket to TechCrunch Disrupt's Expo!Alright, throat clearing aside, here's what we got into this week: $700M water? Yeah, the Liquid Death round was a big deal in the news this week because everyone had an opinion on the matter. Us included. While there's good reason to doubt the DTC model today -- cough cough, public markets -- Alex was on hand to stand up for the, er, near unicorn.How much should you pay your staff? From there it was time to chat about fair compensation, and how a startup called Comprehensive wants to take a crack at the question. It just raised $6 million.Duolingo goes shopping! Yes, we've covered this company before. And, yes, it is now public. But Duolingo snapping up another company gave us the chance to yammer a bit about edtech more generally, and we're always going to take that chance.Naver, Poshmark, and Depop: Naver's move to swoop up Poshmark is the story of two major companies finding union. But since the Poshmark deal was similar to the 2021-era Depop deal, it fit into our remit. After all, Poshmark and Depop were both venture darlings once upon a time.Twitter, Elon, round 472: Since we recorded this podcast, there's been even more Elon-Twitter news. God we're tired of it.Kim Kardashian's crypto issue: Far be it from us to give advice, but if you are going to take $250,000 to shill a shitcoin, do disclose the payment!And that is our show. We're on a regular schedule next week, and then live the week after!Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

60-Second Science
Engineering the Treatment of Early-Stage Lung Cancer [SPONSORED]

60-Second Science

Play Episode Listen Later Oct 7, 2022 6:03 Very Popular


Early-stage lung cancers are not only difficult to diagnose—they’ve also proven difficult to curatively treat.

The aSaaSins Podcast
Legendary educator Esther Wojcicki and CEO Ari Memar talk about disrupting early stage education

The aSaaSins Podcast

Play Episode Listen Later Oct 7, 2022 33:48


Legendary educator and the Godmother of Silicon Valley, Esther Wojcicki, and her co Founder and CEO of Tract, Ari Memar, join the show to talk about:- Esther's approach to empowering kids to be successful and how to raise successful kids.- How Ari and Esther are disrupting early stage education with collaborative, peer to peer learning.- Esther's experience working with her daughters, Anne (CEO of 23andMe) and Susan (CEO of YouTube) as her investors, and the dynamic of mixing family and business.

MarTech Podcast // Marketing + Technology = Business Growth
How Your Early Stage Company Can Survive and Thrive -- Tyler Elliston // Right Side Up

MarTech Podcast // Marketing + Technology = Business Growth

Play Episode Listen Later Oct 7, 2022 16:55


Tyler Elliston, founder and growth advisor of marketing consultant company Right Side Up has many years of experience in the field and a whole lot to share. Today, he drops in to chat with Ben about how you can source and allocate your marketing resources across all your channels. Tyler gets into things like finding your product market fit as an early stage company and the mindset you should have as a marketer at this stage. Do you have the right resources managing your marketing channels as a new company? Show NotesConnect With: Tyler Elliston: Website // LinkedInThe MarTech Podcast: Email // Newsletter // TwitterBenjamin Shapiro: Website // LinkedIn // TwitterSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Tobin, Beast & Leroy
McDaniel reveals Tua suffering from the early stages of....."FOMO"?

Tobin, Beast & Leroy

Play Episode Listen Later Oct 5, 2022 35:56


In Hour 4 We get an update on Tua's health via Head Coach Mike McDaniel. The Coach reveals "FOMO" (Fear of Missing Out) is beginning to kick in for our favorite Fins QB. This leads to a discussion of Bill Belichick thinking he's smarter than doctors. We take another crack at taking some callers as a few of our usual suspects check in and we close the show out with our guys sitting down with Leroy's favorite HEAT player, Victor Oladipo. 

State of Demand Gen
RV E4 - Alternative Funding Options For Early Stage Startups | TikTok Live 17

State of Demand Gen

Play Episode Listen Later Oct 5, 2022 64:49


Chris has returned for round 17 of "CEO Office Hours," our weekly Tik Tok Live event. This week, Chris discussed alternative funding options for early-stage founders and how he approached it at Refine Labs. He also answered audience questions, including: How important is finding a mentor early in your career and how do you do it? What are your thoughts on YouTube shorts vs TikTok right now? What have the business results been from TikTok? And more... Get your question answered each week on Tuesdays, 3pm EST, on Tik Tok Live @chriswalker171 Join the waitlist for The Vault Beta access: www.refinelabs.com/waitlist

BackTable Urology
Ep. 58 RPLND for Early Stage Testicular Cancer with Dr. Clint Cary and Dr. Timothy Masterson

BackTable Urology

Play Episode Listen Later Oct 5, 2022 72:04


In this episode of BackTable Urology, Dr. Aditya Bagrodia discusses retroperitoneal lymph node dissection (RPLND) for early stage testicular cancer with Dr. Clint Cary and Dr. Timothy Masterson from Indiana University School of Medicine. --- CHECK OUT OUR SPONSOR Laurel Road for Doctors https://www.laurelroad.com/healthcare-banking/ --- SHOW NOTES First, the doctors discuss how to approach T1 testicular cancer, which does not show elevated markers or nodal metastases. All the doctors agree that the best approach is just surveillance of the tumor without RPLND, unless there is evidence of somatic transformation. Because some patients have anxiety about just doing surveillance, they assure them that only 10-15% of T1 tumors progress. However, there are different warning signs for different tumor histologies. It is important to get medical oncologists on board quickly in order to have a balanced presentation of treatment options for the patient. The doctors agree that surgeons must counsel patients on the possible complications of RPLND, such as retrograde ejaculation, hernias, and lymphatic leaks, but the probability of these events is low. Next, the doctors discuss whether certain tumor markers can predict the relapse of an early stage testicular cancer. They agree that LDH is not an important marker to check, as it may be falsely elevated. An elevated AFP level can be concerning, but urologists should always put the value into context by comparing to the patient's normal baseline levels and seeing if there is an upward trend. Finally, hCG levels can falsely be elevated by marijuana and hypogonadism. Then, the doctors share their imaging protocol. Standard chest, CT, and pelvic imaging is needed, and Dr. Bagrodia favors chest CT over CXR for better visualization. The doctors also note that more pre-operative imaging immediately before an orchiectomy is not always necessary if the surgeon already has recent imaging. Additionally, the doctors explore approaching T2 testicular cancer, in which there are positive nodes confined to peritoneal nodes. Dr. Masterson and Dr. Cary agree that axial CT imaging is superior. More preoperative factors would be considered such as the focality of the lymph nodes involved, the duration of surveillance time, primary histology of the tumor, and the size of mass. Depending on which lymph nodes are positive (i.e. paraaortic, pelvic. etc.), a surgeon can choose the best RPLND template (modified, unilateral, bilateral). The doctors then explain their intraoperative and postoperative anesthesia protocol. They do not routinely administer DVT prophylaxis before surgery because of the risk of lymphatic leakage. Additionally, they are careful not to disseminate disease by disrupting tumor, which can cause abnormal patterns of metastases Next, the doctors share their post-operative advice for patients. With regards to diets, a lower fat diet will lead to quicker recovery. Ejaculatory function remains normal for patients with unilateral surgery, but should recover within 8-12 months in patients with bilateral surgery. Surgical pathology can determine whether the patient should start adjuvant therapy. For N1 tumors, no adjuvant chemotherapy needed. For N2 tumors, the decision depends on histology and patient factors. Additionally, the doctors explain that extranodal extension does not always mean relapse is inevitable. For this reason, it is important to consider the histology of the tumor. The doctors end the episode by discussing new research on seminoma relapse.

Founding Fearless
11. Pitching with Confidence, Winning $10,000, & All Things Early-Stage Startups with DTV Pitch Competition Winners, Somer Baburek and Apoorva Chintala

Founding Fearless

Play Episode Listen Later Oct 4, 2022 71:19


#11. In this episode, we are interviewing Somer Baburek, co-founder and CEO of Hera Biotech, and Apoorva Chintala, co-founder and CEO of Clocr. Somer and Apoorva both won the KS WELI pitch competition this spring, Dream to Venture, where they were awarded a $10,000 non-diluted grant. Somer currently serves as the President & CEO of Hera Biotech, a women's health company focused on commercializing a non-surgical diagnostic for early detection of endometriosis. Somer earned her MBA with a specialization in Data Analytics, from Louisiana State University. Additionally, Somer attended the University of Texas San Antonio where she graduated Magna Cum Laude with a degree in entrepreneurship. Apoorva Chintala is the CEO and co-founder of Clocr. She started Clocr in 2018 after her grandfather passed away to help people safeguard and pass on their legacy to their loved ones. She also previously served on the Student Advisory Board of the KS WELI. We hope you enjoy! CONNECT WITH SOMER LinkedIn: Somer Baburek LinkedIn: Hera Biotech www.herabiotech.com CONNECT WITH APOORVA LinkedIn: Apoorva Chintala LinkedIn: Clocr www.clocr.com CONNECT WITH THE KS WELI @kswelinstitute foundingfearless@kswelinstitute.org kswelinstitute.utexas.edu "Empowering women to lead and encouraging the world to follow while increasing the number of women-owned and women-led businesses" This podcast is empowered by the Student Board of the Kendra Scott Women's Entrepreneurial Leadership Institute at The University of Texas at Austin. Co-hosts: Kamryn Crossley & Ingrid Villarreal

Modern Day Marketer
Grappling with Growth at an Early Stage Company with Alaina Thompson

Modern Day Marketer

Play Episode Listen Later Oct 3, 2022 23:08


Alaina Thompson, Head of Growth, has been at The Juice since its beginning with Brett. Today, they discuss all things growth marketing and what is and isn't working. Alaina's role has evolved with the company and she's focused not only on acquiring members, but also retention and monetization. A true modern-day marketer, Alaina isn't afraid of a little experimentation to get the ball rolling. 0:00 Intro 0:51 Conversation with Alaina 1:50 Sponsorships/partnerships 5:57 Alaina's role 8:46 Infrastructure 11:06 Product and engineering teams 14:12 Experimenting 16:47 Personalization and paid ads 20:30 Advice 22:30 Outro Join The JuiceFollow The Juice:| Website | Blog | Twitter | LinkedInFollow Alaina:| Twitter | LinkedInFollow Brett:| Twitter | LinkedIn   

Forward Launch Your SaaS | B2B Marketing & Growth for Startups
Why Sales and Marketing Should Be In Harmony for Early Stage Startups -- Michael Young, CEO at Photon Commerce

Forward Launch Your SaaS | B2B Marketing & Growth for Startups

Play Episode Listen Later Oct 3, 2022 31:21


TIMESTAMPS 00:52 - Introduction of how he entered the start-up world 02:35 - How Photon Commerce Started 04:05 - Where is Language Monetizable? 10:38 - Difference between marketing and sales 12:09 - How do you find your market? 18:15 - Success in finding the right people/customers 19:37 - How do you know when to adapt your messaging based on the feedback you are getting GUEST BACKGROUND Michael Young is the founder & CEO of Photon Commerce. Photon accelerates customer acquisition for fintech leaders using instant payments and invoicing through AI and is supported by a venture firm funded by Jeff Bezos and Bill Gates. After dropping out of a Stanford PhD, Michael led advanced R&D programs funded by the Department of Defense, created hundreds of jobs, raised $50M across his venture-backed startups, and took them to acquisitions. MORE FROM PHOTON COMMERCE Photon Commerce's financial AI platform empowers fintech leaders to instantly process B2B payments, invoices, statements, and receipts. Photon's intelligent platform understands and harmonizes data, down to even line-item purchase analytics and prediction. Learn more at photoncommerce.com Reach out to Michael at linkedin.com/in/michaelyoungphoton MAIN INSIGHT Sales and marketing should blend together, especially for an early-stage startup, so you can learn more about your customer and find a product-market-fit fast. KEY TAKEAWAYS Marketing is all about communicating the problem you are solving to the world Marketing is a job of story-telling amazing stories to your team, your investors, your customers, and the world Experiment and try different things to see what will work for your company Content should be optimized for SEO and engagement, and repost Look for a direct marketing strategy Distributing content and getting more traffic is as important as producing content Treat every single market conversation as unique Test your messagesCreate different landing pages Utilize email marketing Visual thumbnail and title are two of the most important components of your content Engagement is as important as creating content A/B test your content PRACTICAL STEPS Find the biggest problem that is worth solving Identify your WHY for solving this problem Share your why to your team and customer to inspire and motivate them TIPS FOR SUCCESS Understand what tools you should use Test your websites and landing pages Use Hotjar to see heatmaps on your website and the behaviors of your users Encourage your marketing team to be analytical and technical Don't hesitate to share some of your content directly and add a personal touch to it Timing on presenting the content is also important

Shaping Opinion
John Abramson: Behind the Curtain at Big Pharma

Shaping Opinion

Play Episode Listen Later Oct 3, 2022 77:18


Author, doctor and college professor John Abramson joins Tim to talk about his book called, “Sickening: How Big Pharma Broke American Health Care and How We can Repair It.” John has been on the faculty of Harvard Medical School for over 25 years, and prior to that spent many years in private practice. In this episode, John about America's healthcare system, which often traces its roots to how drugs are approved for use and marketed to both doctors and consumers. https://traffic.libsyn.com/secure/shapingopinion/John_Abramson_Sickening_auphonic.mp3 Prior to the pandemic, most Americans knew much less, or even cared about how drugs were approved. Vaccines, drugs, medicines and other medical treatments are approved by the Food and Drug Administration, the FDA.  Before the pandemic, most Americans assumed that the FDA and the federal government had their best interests at heart, and that anything approved by the FDA was good for them. When TV viewers watched ads for pharmaceuticals, they assumed that these new drugs had to pass the test of innovation, of efficacy, and that in the end, the new drugs were improvements over the old drugs. The pandemic changed all of that for some, not because of lost trust in the mission of the FDA or other regulatory bodies. And not because of lack of faith in the ability for pharmaceutical companies to provide lifesaving and health-improving treatments. Or their ability to be innovative. What has happened is that America has gotten a peak behind the curtain, and it's not sure it likes what it sees. That's exactly what our guest in this episode has spent much of his life doing. John Abramson is a medical doctor. He's a former expert witness in numerous legal proceedings over the questionable practices of some pharmaceutical companies or executives. Like so many, he entered the medical profession to help people get better or stay healthy. Then he got his own glimpse behind the curtain. Links Sickening: How Big Pharma Broke American Health Care and How We Can Repair It, by John Abramson (Harper Collins' website) Overdo$ed America, by John Abramson (Harper Collins' website) Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis, New England Journal of Medicine (November 23, 2000) Risk of cardiovascular events associated with selective COX-2 inhibitors, Journal of the American Medical Association (August 2001) Vioxx Lawsuits, Drugwatch.com Health Technology Assessment, PubMed.gov E-Mails Suggest Merck Knew Vioxx's Dangers at Early Stage, Wall Street Journal (November 1, 2004) Withheld Study on Vioxx Published This Week in Lancet, Kaiser Health News (June 11, 2009) Diabetes Prevention Program New England Journal Of Medicine 2002, DiabetesTalk.net About this Episode's Guest John Abramson John Abramson MD, MS, has served as a family physician for 22 years. He was twice voted “best doctor” in his area by readers of the local newspapers and three times selected by his peers as one of a handful of best family practitioners in Massachusetts. He has been on the faculty at Harvard Medical School for 16 years, where he has taught primary care and currently teaches health care policy. He currently consults as an expert in litigation involving the pharmaceutical industry and has served as an unpaid consultant to the FBI and Department of Justice. Dr. Abramson has appeared on more than 65 national television shows, including two appearances on the Today Show, and more recently on the Dr. Oz Show. He was written op-ed pieces in the New York Times LA Times and others. In addition to his book, Sickening, He is the author of the national best-selling book Overdo$ed America.

Startup Confidential
Episode 79 - The Last Big Early-Stage Hire is the Toughest

Startup Confidential

Play Episode Play 35 sec Highlight Listen Later Oct 1, 2022 9:33


Wow. Finding a decent head of marketing is easy. But, their ability to move the needle is probably dumb luck, despite their organizational skills. Most marketing fails to move awareness and household penetration because the head of marketing doesn't have a Guggenheim ruthless eye for effective creative that moves hearts and wallets. The problem is so bad, I even launched a course, now live, to help train folks who want to up their effectiveness and become major players at the table. Your Host: Dr. James F. Richardson of Premium Growth Solutions, LLC www.premiumgrowthsolutions.comPlease send feedback on this or other episodes to: admin@premiumgrowthsolutions.com

Equity
We're all just a Hop, Skip and a Drive away from a better Hustle

Equity

Play Episode Listen Later Sep 30, 2022 39:18 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines. Before we get into this week's show notes, some programming notes:First up, use code “EQUITY” for a special listener discount for Disrupt tickets. We're less than one month away!We also have a special for those impacted by layoffs. If you were laid off, go here to get a free ticket to TechCrunch Disrupt's Expo.Ok, now to the show. This week, Natasha, Mary Ann and Rebecca took the mic, with Theresa on production duty, to talk through quite a diverse news cycle. Our deals of the week were Scout, HopSkipDrive and Hustle Fund's new fund (so I think you finally get the headline of this show).Then we jumped into the human side of the layoff story, as Mary Ann and Christine dug into four stories of those impacted by the Better.com layoff spree.https://techcrunch.com/2022/09/28/better-com-employees-detail-their-experiences/ After that, we debated whether or not the Adobe/Figma deal will spur more M&A considering the lack of companies going public and the state of the venture market.Speaking of the venture market, we ended with a discussion about how VCs are funding again, but focusing on certain stages, and then looked ahead at what Q4 might look like. Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

The Blind Ambition with Jack Kelly
Wayne Hu, Managing Director, Early Stage Venture at SignalFire: Everything You Wanted to Know About Venture Capital

The Blind Ambition with Jack Kelly

Play Episode Listen Later Sep 28, 2022 48:58


Wayne Hu, Managing Director, Early Stage Venture at SignalFire It seems like everyone is a venture capitalist these days. Wayne outlines what it really takes to be a venture capitalist. He breaks down the VC career path from entry-level to becoming a prolific investor, what his day-to-day is like, and the business model behind investing with other people's money. https://teamblind.onelink.me/6Ubn/b1ecb098

The Fellow on Call
Episode 031: Lung Cancer Series, Pt. 8: Surgical considerations in early stage NSCLC

The Fellow on Call

Play Episode Listen Later Sep 28, 2022


Lung cancer is one of the most commonly diagnosed type of cancer and so it is fitting that we start the first of our disease-specific oncology series with this diagnosis. This week, we sit down with Thoracic Surgeon, Dr. Jane Yanagawa to discuss surgical considerations in treatment of NSCLC. * How do you choose what type of surgical resection to do?- Considerations: --Lung anatomy --Location of the nodule within lung--Lymph node involvement-Options: --Pneumonectomy: removal of whole lung --Lobectomy: remove a whole lobe--Segmentectomy/sublobar resection: part of a lobe* What does “adequate margins” mean? And how do you know if it's enough?- If you're removing the whole lobe, it does not matter as much - If you're doing a segmentectomy, you want to have samples evaluated while in the OR because if there is signs of more disease that initially thought, you would take this one step further and do a lobectomy. - Need to consider the patient's situation - how good is their status * Why does preoperative workup matter?- Pulmonary function tests: Surgeons are looking at the %FEV1 and %DLCO to then predict what their function would be AFTER surgery. After surgery, they want to ensure patient has %FEV1 or %DLCO >40%. - Lung anatomy: In patients with COPD and endobronchial lesions, sometimes they also get V/Q scans to evaluate ratio- Cardiac echo: Important in pneumonectomy where removal of lung tissue will also remove a significant amount of blood vessels. Want to rule out pulmonary hypertension pre-operatively. - Pulmonary hypertension can also affect someone's survival while they're ventilating with only one lung during the procedure (“single lung ventilation”). - Smoking status: Smoking can increase complications by ~60%. - Pre-habilitation: Encouraging patients to be fit prior to surgery with walking, nutrition, +/- pulmonary rehabilitation* What is “VATS”?- VATS stands for video-assisted thoracoscopic surgery; it is not, in itself, a procedure. But a VATS allows for minimally invasive surgery through the use of a camera. - It involves three incisions (axilla, lowest part of mid-axillary line, one posterior)* In what scenario is a mediastinoscopy warranted? - Needed after EBUS if there is still high index of suspicion for cancer involvement in lymph nodes, even if lymph nodes are negative from EBUS* What is “systematic lymph node sampling”?- An organized way to sample lymph nodes, including all lymph nodes that are along the way, not just the ones that may be involved * As a surgeon, how do you determine if a patient is okay for surgery if the mass is invading another structure?- Need to take the anatomy into consideration - are there major blood vessels or nerves there, for instance, which can impact outcome and recovery.* When should we consider induction chemotherapy from a surgeon's perspective?- Lots of changes in this sphere coming; lots of discrepancy between institutions when there is N2 disease - In Dr. Yanagawa's opinion, anyone with N2 disease should get neoadjuvant therapy * If there is neoadjuvant chemoradiation given, how does that effect your surgery?- Radiation increases scar tissue in the lung tissue. But what is worse is that radiation neoadjuvantly may make wound healing more difficult. She does not prefer radiation pre-operatively- Chemotherapy also adds scar tissue*How does neoadjuvant IO therapy affect scar tissue formation?- The hilum and lymph nodes are more swollen, but does not translate to more complications - She has even seen patients who had gotten IO for another cancer and then get lung cancer, she can still appreciate swollen nodes!* How long after surgery is it safe to start adjuvant therapy?- If patient has a complication from surgery, would not start right away. It is important to discuss with the surgeon about when it is okay to proceed with adjuvant therapy. - If patient has good recovery/without complications, okay to start about 4 weeks after- There is no good guidance yet about when it is safe to start IO after surgery About our guest: Jane Yanagawa, MD is an Assistant Professor of Thoracic Surgery at the UCLA David Geffen School of Medicine and the UCLA Jonsson Comprehensive Cancer Center. She completed medical school at Baylor College of Medicine, after which she went to UCLA for her surgical residency. She went onto Memorial Sloan-Kettering for her Thoracic Surgery Fellowship. In addition to her practice as a thoracic surgeon at UCLA, Dr. Yanagawa also sits on the NCCN NSCLC guidelines committee! We are so grateful she was able to join us despite her very busy schedule! Please visit our website (TheFellowOnCall.com) for more information Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Investing in Regenerative Agriculture
186 Rose Marcario - From growing Patagonia to $1b in sales to making early stage regen tech investments

Investing in Regenerative Agriculture

Play Episode Listen Later Sep 27, 2022 60:02


A conversation with Rose Marcario, former president and CEO of Patagonia and current founding partner of ReGen Ventures, about moving from an organic food company to joining an early-stage VC fund focused on regenerative technologies.---------------------------------------------------Join our Gumroad community, discover the tiers and benefits on www.gumroad.com/investinginregenag. Support our work:Share itGive a 5-star ratingBuy us a coffee… or a meal! www.Ko-fi.com/regenerativeagriculture----------------------------------------------------During her time as CEO of Patagonia, which grew to over a billion dollars a year with a very strong activist focus. They launched their organic food company Patagonia Provisions and she also co-founded the Regenerative Organic Alliance. So why after she left that role, and that stage, she joined the early-stage VC fund focused on regenerative technologies?More about this episode on https://investinginregenerativeagriculture.com/rose-marcario.Find our video course on https://investinginregenerativeagriculture.com/course.----------------------------------------------------For feedback, ideas, suggestions please contact us through Twitter @KoenvanSeijen, or get in touch through the website www.investinginregenerativeagriculture.com. Join our newsletter on www.eepurl.com/cxU33P. The above references an opinion and is for information and educational purposes only. It is not intended to be investment advice. Seek a duly licensed professional for investment advice.  Support the show Support the show

Equity
Hey, look, some startups are still raising money

Equity

Play Episode Listen Later Sep 26, 2022 9:34 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.Don't forget that the code “EQUITY” can save you money on Disrupt tickets and TechCrunch+ access. And it makes us here on the show look good!Markets: Stocks are mostly down around the world today, taking especially large hits in Asia. U.S. shares are set to fall as well when they begin to trade. Major cryptos are also off in the last 24 hours, but not enough to make a fuss about.Startups: Today we took a look at new fundraises at Vendease, an African logistics company in the food space, and Disperse, a U.K-based construction tech company that wants to map building sites. That market, it turns out, is huge.Quick Hits: Do Kwon has been hit with a red notice, which means that he will likely soon be in custody. However, some are irked that he's in trouble for causing a financial meltdown and losing a lot of folks' money. What's the argument there? That he wasn't being malicious, and instead was merely, we presume, stupid. Not a great argument in terms of making Do Kwon look good, but that's where we are. Also in the mix: The new iPhone is being built in India and TikTok may find regulatory reprieve.Closing Riff: Goodbye Q3 2022, hello Q4 2022. This is the last Equity Monday of the third quarter, a period that few of us are going to look back on and miss.That's our show! We are back Wednesday and Friday!Equity drops every Monday at 7 a.m. PT and Wednesday and Friday at 6 a.m. PT, so subscribe to us on Apple Podcasts, Overcast, Spotifyand all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together and more!

Modern Day Marketer
Selling at an Early Stage Company with Kate VanLue

Modern Day Marketer

Play Episode Listen Later Sep 26, 2022 28:12


Brett is joined by Kate VanLue, Director of Sales at The Juice. She shares some of the challenges and advantages of selling at The Juice and how her sales process has evolved. Some marketers understand the value of The Juice right away and are easy to onboard, while other marketers need more time or have constraints in budget or from leadership. 0:00 Intro 1:09 Conversation with Kate 2:30 Selling a new product 4:53 Sales process at The Juice 7:00 Communicating value 10:30 Quality over quantity 15:10 Profile of The Juice user 17:40 Challenges from leadership 21:45 Price 25:00 Breaking through to new customer 27:18 Outro Join The JuiceTo learn more about Category Pages, visit app.thejuicehq.com/categoriesFollow The Juice:| Website | Blog | Twitter | LinkedInFollow Kate:| LinkedIn |Talk with KateFollow Brett:| Twitter | LinkedIn 

Equity
When VCs fund the thing you didn't think they'd ever fund

Equity

Play Episode Listen Later Sep 23, 2022 38:13 Very Popular


Hello and welcome back to Equity, a podcast about the business of startups, where we unpack the numbers and nuance behind the headlines.Coming to hang with us at Disrupt, where Equity is kicking off the entire event? Use code 'EQUITY' to save 15% on your tickets. Hell yeah, and see you there!Alex, Natasha and Mary Ann jumped on the mic, with Theresa running production, to talk through the biggest headlines from the week!Deals of the Week! This time 'round we had Polywork raising $28 million, Block Party raising $4.8 million, and Remofirst and its own recent fundraise. Naturally we had to leave 234 deals on the cutting room floor, but these were the ones we could not wait to chat more about. Also, don't Polywork, Block Party and Remofirst sound like fun people to get dinner with? Just us?Insurtech goes Niche: From there it was time to riff on a series of stories from Mary Ann, focused on specialized insurtech companies, and the fact that Pie just proved that it is still possible to raise nine-figures as an insurance-focused startup.The Great Delivery Wars: Next up was News From Instacart, including the fact that its IPO is still underway, and that it is busy launching products as it meanders towards the public markets. It turns out as well that a bunch of companies would love more than a slice of its business. Doordash, for one.Layoffs and more: And then layoffs. Layoffs at Metafy, layoffs at Sundae, and layoffs at Ola. We, however, found a silver lining and ran with that.Equity drops every Monday at 7 a.m. PDT and Wednesday and Friday at 6 a.m. PDT, so subscribe to us on Apple Podcasts, Overcast, Spotify and all the casts. TechCrunch also has a great show on crypto, a show that interviews founders, a show that details how our stories come together, and more!

Startup Life Show with Ande Lyons
EP 229 Female VC Actively Seeking Early-Stage B2B Female Led Enterprises

Startup Life Show with Ande Lyons

Play Episode Listen Later Sep 23, 2022 59:17


Our guest, Pascale Diaine, a partner at Storm Ventures, is passionate about and committed to investing in female founders of early-stage B2B enterprises.Her investment thesis focuses on sales and marketing automation, AI/ML, IoT, retail tech, AR, computer vision, and robotics applied to the enterprise space.Before joining Storm, Pascale founded Orange Fab, the corporate accelerator of the European Telco Orange, and managed cohorts including Talkdesk (today worth $3B), Wonolo, Rallyteam (acquired by Workday), Verdigris, Pixlee, and many more.She also started an alliance of corporations piggybacking on Orange Fab's deal-flow and helping cohorts land their first Fortune 500 customers. To learn more about Storm Ventures, please visit: https://www.stormventures.com/Follow and connect with Pascale and Storm Ventures via these social platforms:LinkedIn: https://www.linkedin.com/in/paskale/ and https://www.linkedin.com/company/storm-ventures/ Twitter: https://twitter.com/pascale and https://twitter.com/stormventures Thank you for carving out time to improve your Founder Game - when you do better, your business will do better - cheers!Ande ♥https://andelyons.com#bestyoutubechannelforstartups #venturecapital #femalefounders #b2bsaas Psst: If you're thinking “Wow – that Andelicious Advice really helped me,” please buy me a cup of coffee – a breve cappuccino will make my heart and mind sing with joy and keep me powered to serve more founders – thank you! You'll also find some Andelicious documents and resources for startups ready to download and ease your founder journey. ♥https://www.buymeacoffee.com/andelyonsCONNECT WITH ME ONLINE: https://andelyons.com https://twitter.com/AndeLyonshttps://www.facebook.com/StartupLifew... https://www.linkedin.com/in/andelyons/ https://www.instagram.com/ande_lyons/ https://www.pinterest.com/andelyons/ https://angel.co/andelyons TikTok: @andelyonsANDELICIOUS ANNOUNCEMENTSArlan's Academy: https://arlansacademy.com/Scroobious - use Ande15 discount code: https://www.scroobious.com/https://bit.ly/AAElizabethYinTune in to Mia Voss' Shit We Don't Talk About podcast here: https://shitwedonttalkaboutpodcast.com/ANDELICIOUS RESOURCES:JOIN STARTUP LIFE LIVE MEETUP GROUPGet an alert whenever I post a new show!https://bit.ly/StartupLifeLIVEAGORAPULSEMy favorite digital marketing dashboard is AGORAPULSE – it's the best platform to manage your social media posts and presence! Learn more here: http://www.agorapulse.com?via=ande17STARTUP DOX Do you need attorney reviewed legal documents for your startup? I'm a proud community partner of Startup Dox, a new service provided by Selvarajah Law PC which helps you draw out all the essential paperwork needed to kickstart your business in a super cost-effective way. All the legal you're looking for… only without confusion or frustration. EVERY filing and document comes with an attorney review. You will never do it alone. Visit https://www.thestartupdox.com/ and use my discount code ANDE10 to receive 10% off your order.SPONSORSHIPIf you resonate with the show's mission of amplifying diverse founder voices while serving first-time founders around the world, please reach out to me to learn more about making an impact through sponsoring the Startup Life LIVE Show! ande@andelyons.com.Ande ♥